You are here » Home » Markets » Mutual Funds

Tata India Pharma & Healthcare Fund-Direct (IDCW)

Fund Class : Equity - Pharma
Fund House : Tata Mutual Fund
Aum(Rs Cr) : 73.67
NAV 25 May 2022 17.41 -0.16
(-0.91%)

NAV High-Low (in Rs)

ONE Mth 538.47
538.47
52-WEEk 528.26
609.91

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes - - - - 23.02
Sensex 2.77 -5.41 -5 6.34 37.58
Nifty 2.28 -5.99 -5.03 5.68 36.52

Competitors of Tata India Pharma & Healthcare Fund-Direct (IDCW) fund

Schemes FUND
SIZE()
1-Wk
(%)
1-Mth
(%)
3-Mth
(%)
6-Mth
(%)
1-Yr
(%)
SBI Equity Minimum Variance - Regular (IDCW) 128.64 -0.54 -2.88 -0.42 -4.48 5.51
› More

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 73.67 (31 Jan 16)
Inception Date 04 Dec 15
Fund Manager Meeta Shetty

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 30 Apr 2022
Category Share (%)
Equity 94.37
Net CA & Others 1.91
Reverse Repo 3.70
› More
   As On 30 Apr 2022
Sector Name Amount
Finance & Investments 0.48
Healthcare 19.15
NA 5.61
Pharmaceuticals - Indian - Bulk Drugs 9.22
Pharmaceuticals - Indian - Bulk Drugs & Formln 58.95
Pharmaceuticals - Indian - Formulations 1.24
Pharmaceuticals - Multinational 5.33
› More
   As On 30 Apr 2022
Company Name
Sun Pharma.Inds. 14.95
Dr Reddy's Labs 10.03
Cipla 9.38
Apollo Hospitals 6.97
Alkem Lab 6.22
Ipca Labs. 5.96
Fortis Health. 4.99
Lupin 4.47
› More

Fund DETAILS

Asset Management Co.

Registered Address

Tata Asset Management Ltd,

1903 B-Wing Parinee Crescenzo
G-Block Bandra Kurla Complex
Bandra East Mumbai - 400051

Phone: 6657 8282. | Fax: 2261 3782.

Email: service@tataamc.com

Website: www.tatamutualfund.com

.